Page 5 - Instem Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Instem plc, Director/PDMR Shareholding

Investegate announcements from Instem plc, H2 China Market Update

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Instem lays foundations for next level in drug development services “Businesses in life sciences have so many suppliers and so many different solutions that it is a huge opportunity.” Two acquisitions this year already underline the growing ambition of pharmaceutical services group Instem PLC (LON:INS). In a sector where its customers are usually valued in the billions, a desire by Instem to bulk up is understandable. The business currently is valued at £150mln (at 680p)  which by AIM standards is meaty enough but in a pharma sector dominated by such as Pfizer, Merck and AstraZeneca, ha...